ARCHIVES

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

Cancer PAC Advocated At AACR Meeting

May 23, 1986

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

March 15, 1991

CALGB Chairman Schilsky To Step Down After 15 Years Leading Cooperative Group.

February 1, 2008

UICC Names Banker As Chief Executive

September 11, 2009

Surprise Finding On HRT Stops Large Trial, Women Advised To Reconsider Long-Term Use Due to Increased Breast Cancer Risk

July 12, 2002